AbbVie is testing its oral drug upadacitinib in a Phase 3 trial for patients with hidradenitis suppurativa (HS) who failed ...

Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating ...

Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

A new study published in the journal of PloS One found a significant link between smoking and a heightened risk of ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

A new study published in the Journal of American Medical Association showed that the prevalence of physical and mental comorbidities was greater in children with hidradenitis ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

Women with hidradenitis suppurativa perceived less respectful and effective communication from physicians than men.

KUWAIT CITY, June 21: The Kuwait Dermatologists Association (KDA) launched a nationwide awareness campaign on Saturday titled ...

Hidradenitis Suppurativa (HS) has a significant impact on the wellbeing of people living with the condition, the National Health Service (NHS), and broader society, but HS and its range of impacts are ...